Treatment of tuberculosis in HIV-infected patients:: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin

被引：25
|
作者：
Moreno, S [1 ]
Podzamczer, D
Blázquez, R
Iribarren, JA
Ferrer, E
Reparaz, J
Peña, JM
Cabrero, E
Usán, L
机构：
[1] Hosp Ramon & Cajal, Dept Infect Dis, E-28034 Madrid, Spain
[2] Bellvitge Hosp, Dept Infect Dis, Barcelona, Spain
[3] Hosp Morales Meseguer, Dept Microbiol & Infect Dis, Murcia, Spain
[4] Hosp NS Aranzazu, Dept Infect Dis, San Sebastian, Spain
[5] Hosp Navarra, Dept Infect Dis, Pamplona, Spain
[6] Hosp La Paz, AIDS Unit, Madrid, Spain
[7] Abbott Labs, Dept Med, Madrid, Spain
来源：
AIDS | 2001年 / 15卷 / 09期
关键词：
D O I：
10.1097/00002030-200106150-00018
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1185 / 1187
页数：3
相关论文
共 50 条
  • [41] Predictors of primary non-adherence to concomitant chronic treatment in HIV-infected patients with antiretroviral therapy
    Borrego, Yolanda
    Gomez-Fernandez, Encarnacion
    Jimenez, Rocio
    Cantudo, Rosa
    Almeida-Gonzalez, Carmen V.
    Morillo, Ramon
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2018, 25 (03) : 127 - 131
  • [42] Antiretroviral therapy of HIV-infected patients
    Gölz, J
    MEDIZINISCHE WELT, 1999, 50 (06): : 223 - 229
  • [43] TREATMENT OF TUBERCULOSIS IN HIV-INFECTED PATIENTS, IN ZAIRE - REPLY
    PERRIENS, JH
    STLOUIS, ME
    PRIGNOT, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (08): : 520 - 520
  • [44] Factors that complicate the treatment of tuberculosis in HIV-infected patients
    Dworkin, MS
    Adams, MR
    Cohn, DL
    Davidson, AJ
    Buskin, S
    Horwitch, C
    Morse, A
    Sackoff, J
    Thompson, M
    Wotring, L
    McCombs, SB
    Jones, JL
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (04) : 464 - 470
  • [45] Kaletra® (lopinavir/ritonavir), an antiretroviral therapy for HIV-infected individuals.
    Sham, HL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U1186 - U1186
  • [46] Is treatment with ritonavir a risk factor for myocardial infarction in HIV-infected patients?
    Eriksson, U
    Opravil, M
    Amann, FW
    Schaffner, A
    AIDS, 1998, 12 (15) : 2079 - 2080
  • [47] Pharmacokinetic interaction between rifampin and the combination of indinavir and low-dose ritonavir in HIV-infected patients
    Justesen, US
    Andersen, ÅB
    Klitgaard, NA
    Brosen, K
    Gerstoft, J
    Pedersen, C
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) : 426 - 429
  • [48] Knowledge of Antiretroviral Treatment and Associated Factors in HIV-Infected Patients
    Nguyen, Lam Van
    Nguyen, Thao N. P.
    Thach, Anh N.
    Lam, Anh N.
    Lam, Duc Q.
    Duong, Chu X.
    Pham, Suol T.
    Nguyen, Thao H.
    Perwitasari, Dyah A.
    Taxis, Katja
    Nguyen, Phuong M.
    Nguyen, Thang
    HEALTHCARE, 2021, 9 (04)
  • [49] Clinical characteristics and antiretroviral treatment of older HIV-infected patients
    Mercedes Gimeno-Gracia
    María José Crusells-Canales
    María José Rabanaque-Hernández
    International Journal of Clinical Pharmacy, 2014, 36 : 1190 - 1195
  • [50] Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: An update
    Cressey, Tim R.
    Lallemant, Marc
    INFECTION GENETICS AND EVOLUTION, 2007, 7 (02) : 333 - 342
12345